These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31028990)

  • 1. Design, synthesis and photoinduced DNA cleavage studies of [1,2,4]-triazolo[4,3-a]quinoxalin-4(5H)-ones.
    Sumran G; Aggarwal R; Mittal A; Aggarwal A; Gupta A
    Bioorg Chem; 2019 Jul; 88():102932. PubMed ID: 31028990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copper(II) chloride mediated synthesis and DNA photocleavage activity of 1-aryl/heteroaryl-4-substituted-1,2,4-triazolo[4,3-a]quinoxalines.
    Aggarwal R; Sumran G; Kumar V; Mittal A
    Eur J Med Chem; 2011 Dec; 46(12):6083-8. PubMed ID: 22051064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ruthenium(II) complexes of saccharin with dipyridoquinoxaline and dipyridophenazine: Structures, biological interactions and photoinduced DNA damage activity.
    Kumar P; Dasari S; Patra AK
    Eur J Med Chem; 2017 Aug; 136():52-62. PubMed ID: 28482217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of [1,2,3]triazolo[1,5-a]quinoxalin-4(5H)-ones through copper-catalyzed tandem reactions of N-(2-haloaryl)propiolamides with sodium azide.
    Yan J; Zhou F; Qin D; Cai T; Ding K; Cai Q
    Org Lett; 2012 Mar; 14(5):1262-5. PubMed ID: 22335274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of certain substituted quinoxalines as antimicrobial agents (Part II).
    Badran MM; Abouzid KA; Hussein MH
    Arch Pharm Res; 2003 Feb; 26(2):107-13. PubMed ID: 12643584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights into the visible-light-induced DNA cleavage activity of dipyridoquinoxaline complexes of bivalent 3d-metal ions.
    Roy M; Pathak B; Patra AK; Jemmis ED; Nethaji M; Chakravarty AR
    Inorg Chem; 2007 Dec; 46(26):11122-32. PubMed ID: 18044877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triazolopyridopyrimidines: an emerging family of effective DNA photocleavers. DNA binding. Antileishmanial activity.
    Adam R; Bilbao-Ramos P; Abarca B; Ballesteros R; González-Rosende ME; Dea-Ayuela MA; Estevan F; Alzuet-Piña G
    Org Biomol Chem; 2015 May; 13(17):4903-17. PubMed ID: 25812028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and excitatory amino acid pharmacology of a series of heterocyclic-fused quinoxalinones and quinazolinones.
    McQuaid LA; Smith EC; South KK; Mitch CH; Schoepp DD; True RA; Calligaro DO; O'Malley PJ; Lodge D; Ornstein PL
    J Med Chem; 1992 Sep; 35(18):3319-24. PubMed ID: 1382133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unexpected imidazoquinoxalinone annulation products in the photoinitiated reaction of substituted-3-methyl-quinoxalin-2-ones with N-phenylglycine.
    De la Fuente JR; Cañete Á; Jullian C; Saitz C; Aliaga C
    Photochem Photobiol; 2013; 89(6):1335-45. PubMed ID: 24033113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinoxalin-2(1H)-one derivatives as inhibitors against hepatitis C virus.
    Liu R; Huang Z; Murray MG; Guo X; Liu G
    J Med Chem; 2011 Aug; 54(16):5747-68. PubMed ID: 21761853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, molecular modeling and anti-proliferative evaluation of novel quinoxaline derivatives as potential DNA intercalators and topoisomerase II inhibitors.
    Ibrahim MK; Taghour MS; Metwaly AM; Belal A; Mehany ABM; Elhendawy MA; Radwan MM; Yassin AM; El-Deeb NM; Hafez EE; ElSohly MA; Eissa IH
    Eur J Med Chem; 2018 Jul; 155():117-134. PubMed ID: 29885574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and molecular docking study of novel quinoxalin-2(1H)-ones as anti-tumor active agents with inhibition of tyrosine kinase receptor and studying their cyclooxygenase-2 activity.
    Galal SA; Khairat SH; Ragab FA; Abdelsamie AS; Ali MM; Soliman SM; Mortier J; Wolber G; El Diwani HI
    Eur J Med Chem; 2014 Oct; 86():122-32. PubMed ID: 25147154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,2,4-triazolo[4,3-a]quinoxalin-1-one moiety as an attractive scaffold to develop new potent and selective human A3 adenosine receptor antagonists: synthesis, pharmacological, and ligand-receptor modeling studies.
    Colotta V; Catarzi D; Varano F; Calabri FR; Lenzi O; Filacchioni G; Martini C; Trincavelli L; Deflorian F; Moro S
    J Med Chem; 2004 Jul; 47(14):3580-90. PubMed ID: 15214785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA binding and oxidative DNA cleavage activity of (mu-oxo)diiron(iii) complexes in visible light.
    Roy M; Santhanagopal R; Chakravarty AR
    Dalton Trans; 2009 Feb; (6):1024-33. PubMed ID: 19173085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copper-Catalyzed Oxidative [3 + 2]-Annulation of Quinoxalin-2(1
    Yadav A; Yadav A; Tripathi S; Dewaker V; Kant R; Yadav PN; Srivastava AK
    J Org Chem; 2022 Jun; 87(11):7350-7364. PubMed ID: 35587158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of some new quinoxalines and 1,2,4-triazolo[4,3-a]-quinoxalines for evaluation of in vitro antitumor and antimicrobial activities.
    El-Hawash SA; Habib NS; Kassem MA
    Arch Pharm (Weinheim); 2006 Oct; 339(10):564-71. PubMed ID: 17009301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and biological evaluation of 3-vinyl-quinoxalin-2(1H)-one derivatives as novel antitumor inhibitors of FGFR1.
    Liu Z; Yu S; Chen D; Shen G; Wang Y; Hou L; Lin D; Zhang J; Ye F
    Drug Des Devel Ther; 2016; 10():1489-500. PubMed ID: 27217720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1,2,4-Triazolo[1,5-a]quinoxaline as a versatile tool for the design of selective human A3 adenosine receptor antagonists: synthesis, biological evaluation, and molecular modeling studies of 2-(hetero)aryl- and 2-carboxy-substituted derivatives.
    Catarzi D; Colotta V; Varano F; Lenzi O; Filacchioni G; Trincavelli L; Martini C; Montopoli C; Moro S
    J Med Chem; 2005 Dec; 48(25):7932-45. PubMed ID: 16335918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-aryl-8-chloro-1,2,4-triazolo[1,5-a]quinoxalin-4-amines as highly potent A1 and A3 adenosine receptor antagonists.
    Catarzi D; Colotta V; Varano F; Calabri FR; Lenzi O; Filacchioni G; Trincavelli L; Martini C; Tralli A; Montopoli C; Moro S
    Bioorg Med Chem; 2005 Feb; 13(3):705-15. PubMed ID: 15653338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of potent and multifunctional aldose reductase inhibitors based on quinoxalinones.
    Qin X; Hao X; Han H; Zhu S; Yang Y; Wu B; Hussain S; Parveen S; Jing C; Ma B; Zhu C
    J Med Chem; 2015 Feb; 58(3):1254-67. PubMed ID: 25602762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.